SAMSUNG PHARM. Co., LTD. Market Cap

SAMSUNG PHARM. Co., LTD. has a market cap or net worth of 153.89 billion as of August 14, 2025. Its market cap has increased by 2.25% in one year.

Market Cap

153.89B

Enterprise Value

n/a

Revenue

44.29B

Ranking

n/a

PE Ratio

12.11

Stock Price

1,610.00

Market Cap Chart

Since August 31, 1995, SAMSUNG PHARM. Co., LTD.'s market cap has increased from 17.88B to 153.89B, an increase of 760.43%. That is a compound annual growth rate of 7.44%.

Market Cap History

Date	Market Cap	% Change
Aug 13, 2025	153.32B	5.92%
Dec 30, 2024	144.76B	-0.84%
Dec 28, 2023	145.99B	-18.99%
Dec 29, 2022	180.22B	-45.48%
Dec 30, 2021	330.57B	-11.17%
Dec 30, 2020	372.12B	50.47%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	72.67T
Celltrion	38.01T
ALTEOGEN	23.22T
Yuhan	8,309.02B
SK Biopharmaceuticals	7,737.35B
Peptron	7,117.34B
PharmaResearch	6,950.67B
LigaChem Biosciences	5,361.69B

Market Cap Rankings